Dr Jay Wei is responsible for managing SERI-IMCB program in retinal angiogenic diseases(SIPRAD) a team of clinicians, scientists,research fellows, laboratory and clinical staff , His main research interests are aged-related macular degeneration and diabetic retinopathy. He was Pricipal Scientist of Department of Biological Sciences,Allergan, California. Prior to Allergan, Dr Wei was scientific leader of Intrexon Ophthalmic Division,Gemantown, Maryland.Dr Wei also worked at Alcon Laboratories,Fort Worth, Texas for 10 years and Novartis Institute of Biomedical Research (NIBR) for 2 years as key Senior Scientist of Degenerative Diseases and Retinopathy program. He received his medical training form Binzhou Medical University ,Shandong Province,China, attained his master degree in physiology from Xi’an Jiaotong University Medical Center ,and a PhD in retianl biology from Chinese Academy of Science,Shanghai,China.After graduation, he moved to United States to complete his posidoctoral training in retinal biology from Department of Ophthalmology and Visual Science, Yale University School of Medicine. From 1998 to 2001, he was a research junoir faculty in the sarne department at Yale. Dr Wei has nearly 25 years of experience in retinal biology studies,including 14 years industry experience and 11 years academic experience in various retinal programs.He received the Novartis NIBR Spotlight Award in 2012.